Domingueti Caroline Pereira, Fuzatto Jéssica A, Fóscolo Rodrigo B, Reis Janice S, Dusse Luci M, Carvalho Maria das Graças, Gomes Karina B, Fernandes Ana Paula
Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de São João Del-Rei, Campus Centro Oeste Dona Lindu, Divinópolis, Minas Gerais, Brazil.
Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Clin Chim Acta. 2016 Aug 1;459:1-4. doi: 10.1016/j.cca.2016.05.011. Epub 2016 May 18.
We evaluated the association between plasma levels of VWF, ADAMTS13 and d-Dimer, which consist on endothelial dysfunction and hypercoagulability biomarkers, and cystatin C with retinopathy in type 1 diabetic patients.
Patients were classified according to presence (n=55) or absence (n=70) of retinopathy. Plasma levels of VWF, ADAMTS13, d-Dimer and cystatin C were evaluated by ELISA and ADAMTS13 activity was evaluated by FRET.
Plasma levels of VWF (p=0.033), ADAMTS13 activity (p=0.014), d-Dimer (p=0.002) and cystatin C (p<0.001) were elevated in diabetic patients with retinopathy compared to those without this complication. The multivariate logistic regression analysis showed that ADAMTS13 activity (p=0.031) d-Dimer (p=0.015) and cystatin C (p=0.001) remained associated with retinopathy after adjustment for age, diabetes duration, use of statin, use of ACEi or angiotensin antagonist, use of acetylsalicylic acid and glomerular filtration rate.
ADAMTS13 activity, d-Dimer and cystatin C are associated with retinopathy in type 1 diabetic patients and are promising biomarkers for the diagnosis and monitoring of diabetic retinopathy.
我们评估了血管性血友病因子(VWF)、含血小板解聚蛋白和金属蛋白酶13(ADAMTS13)及D - 二聚体(它们是内皮功能障碍和高凝状态生物标志物)的血浆水平与1型糖尿病患者视网膜病变中胱抑素C之间的关联。
根据是否存在视网膜病变将患者分类(存在视网膜病变的患者n = 55,不存在视网膜病变的患者n = 70)。采用酶联免疫吸附测定法(ELISA)评估VWF、ADAMTS13、D - 二聚体和胱抑素C的血浆水平,采用荧光共振能量转移法(FRET)评估ADAMTS13活性。
与无此并发症的糖尿病患者相比,患有视网膜病变的糖尿病患者的VWF血浆水平(p = 0.033)、ADAMTS13活性(p = 0.014)、D - 二聚体(p = 0.002)和胱抑素C(p < 0.001)升高。多因素逻辑回归分析显示在调整年龄、糖尿病病程、他汀类药物使用情况、血管紧张素转换酶抑制剂(ACEi)或血管紧张素拮抗剂使用情况、阿司匹林使用情况和肾小球滤过率后,ADAMTS13活性(p = 0.031)、D - 二聚体(p = 0.015)和胱抑素C(p = 0.001)仍与视网膜病变相关。
ADAMTS13活性、D - 二聚体和胱抑素C与1型糖尿病患者的视网膜病变相关,是糖尿病视网膜病变诊断和监测中有前景的生物标志物。